These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36535079)

  • 21. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining the Ultrasound Features of Primary Tumor and Axillary Lymph Nodes Can Reduce False-Negative Rate during the Prediction of High Axillary Node Burden in BI-RADS Category 4 or 5 Breast Cancer Lesions.
    Yi CB; Ding ZY; Deng J; Ye XH; Chen L; Zong M; Li CY
    Ultrasound Med Biol; 2020 Aug; 46(8):1941-1948. PubMed ID: 32451195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Whether Morphological Changes in Axillary Lymph Node Have Already Occurred Prior to Metastasis in Breast Cancer Patients by Ultrasound.
    Guo Q; Dong Z; Jiang L; Zhang L; Li Z; Wang D
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redefining ultrasound appearance criteria of positive axillary lymph nodes.
    Duchesne N; Jaffey J; Florack P; Duchesne S
    Can Assoc Radiol J; 2005 Dec; 56(5):289-96. PubMed ID: 16579022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion tensor imaging and diffusion-weighted imaging on axillary lymph node status in breast cancer patients.
    Kurt N; Binboga Kurt B; Gulsaran U; Uslu B; Celik AO; Sut N; Tastekin E; Karabulut D; Tuncbilek N
    Diagn Interv Radiol; 2022 Jul; 28(4):329-336. PubMed ID: 35950277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic performance of T2-weighted imaging and intravoxel incoherent motion diffusion-weighted MRI for predicting metastatic axillary lymph nodes in T1 and T2 stage breast cancer.
    Liu Y; Luo H; Wang C; Chen X; Wang M; Zhou P; Ren J
    Acta Radiol; 2022 Apr; 63(4):447-457. PubMed ID: 33779304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer.
    Zhao M; Wu Q; Guo L; Zhou L; Fu K
    Eur J Radiol; 2020 Aug; 129():109093. PubMed ID: 32512504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the ultrasonographic features of axillary lymph node metastasis in breast cancer].
    Wang YB; Zhang H; Gao W; Zhang L; Yan K; Yin SS; Chen MH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):65-9. PubMed ID: 16737626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy.
    Nori J; Bazzocchi M; Boeri C; Vanzi E; Nori Bufalini F; Mangialavori G; Distante V; Masi A; Simoncini R; Londero V
    Radiol Med; 2005 Apr; 109(4):330-44. PubMed ID: 15883518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
    Choi WH; Yoo IR; O JH; Kim SH; Chung SK
    Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
    Jung NY; Kim SH; Kang BJ; Park SY; Chung MH
    Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of
    Nakano Y; Noguchi M; Yokoi-Noguchi M; Ohno Y; Morioka E; Kosaka T; Takahashi T; Minato H
    Breast Cancer; 2017 Jan; 24(1):121-127. PubMed ID: 27015862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative staging of axillary lymph nodes in breast cancer: ultrasonographic parameters and ultrasound-guided core needle biopsy].
    Torres Sousa MY; Banegas Illescas ME; Rozas Rodríguez ML; Arias Ortega M; González López LM; Martín García JJ; Ruiz Ortega L
    Radiologia; 2011; 53(6):544-51. PubMed ID: 21565373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonographic evaluation of axillary lymph nodes in women with newly diagnosed breast cancer at the university college hospital Ibadan, Nigeria.
    Hafiz A; Adeniji-Sofoluwe AT; Ademola AF; Obajimi MO
    Niger Postgrad Med J; 2018; 25(2):79-86. PubMed ID: 30027918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
    van Nijnatten TJA; Jochelson MS; Lobbes MBI
    Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. False negative results in axillary lymph nodes by ultrasonography and ultrasonography-guided fine-needle aspiration in patients with invasive ductal carcinoma.
    Park SH; Kim EK; Park BW; Kim SI; Moon HJ; Kim MJ
    Ultraschall Med; 2013 Dec; 34(6):559-67. PubMed ID: 23258771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis.
    Wang X; Chen L; Sun Y; Zhang B
    Clin Transl Oncol; 2020 Apr; 22(4):468-473. PubMed ID: 31214929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordant results in
    Parisse-Di Martino S; Faure C; Mognetti T
    Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.
    Park J; Byun BH; Noh WC; Lee SS; Kim HA; Kim EK; Choi CW; Lim SM
    Clin Nucl Med; 2014 Apr; 39(4):e249-53. PubMed ID: 24152622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.